We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Santander
BSBR
$43.5B
| $24.5M | 0.06% |
2,128,902
-886,141
| -29% | -$9.29M |
|
|
GAP
277
The Gap Inc
GAP
$7.37B
| $24.4M | 0.06% |
+781,400
| New | +$25.6M |
|
278
Protolabs
PRLB
$2.13B
| $24.3M | 0.06% |
206,949
+31,065
| +18% | +$3.51M |
|
279
Nokia
NOK
$52.3B
| $24.3M | 0.06% |
4,444,255
-7,323,109
| -62% | -$39.5M |
|
280
EOG Resources
EOG
$70.7B
| $24.3M | 0.06% |
230,600
+223,500
| +3,148% | +$24.1M |
|
281
Universal Health Services
UHS
$10.5B
| $24.2M | 0.06% |
+204,013
| New | +$24.2M |
|
282
KB Financial Group
KB
$43.5B
| $24.1M | 0.06% |
416,549
-263,851
| -39% | -$15.8M |
|
283
Boston Scientific
BSX
$71.5B
| $24M | 0.06% |
878,175
-6,271,672
| -88% | -$170M |
|
|
VAR
284
DELISTED
Varian Medical Systems, Inc.
VAR
| $23.9M | 0.05% |
195,160
-446,055
| -70% | -$53.2M |
|
285
Polaris
PII
$4.07B
| $23.8M | 0.05% |
208,147
+148,747
| +250% | +$17.9M |
|
286
ING
ING
$102B
| $23.5M | 0.05% |
+1,386,572
| New | +$25.7M |
|
287
National Grid
NGG
$81.3B
| $23.5M | 0.05% |
470,116
-893,745
| -66% | -$43.6M |
|
288
iShares MSCI Turkey ETF
TUR
$217M
| $23.4M | 0.05% |
551,564
-1,559,660
| -74% | -$68.5M |
|
289
Compañía de Cervecerías Unidas
CCU
$2.21B
| $23.3M | 0.05% |
793,032
+348,081
| +78% | +$10M |
|
|
JWN
290
DELISTED
Nordstrom
JWN
| $23.3M | 0.05% |
+481,376
| New | +$23.9M |
|
|
VVC
291
DELISTED
Vectren Corporation
VVC
| $23.3M | 0.05% |
364,122
-677,321
| -65% | -$41.9M |
|
292
Southwest Airlines
LUV
$23B
| $23.3M | 0.05% |
+405,900
| New | +$24.4M |
|
|
WBC
293
DELISTED
WABCO HOLDINGS INC.
WBC
| $23M | 0.05% |
171,785
-64,678
| -27% | -$9.37M |
|
294
International Paper
IP
$22B
| $22.8M | 0.05% |
+451,123
| New | +$25.1M |
|
295
Novartis
NVS
$297B
| $22.8M | 0.05% |
314,963
+137,073
| +77% | +$10.4M |
|
296
Textron
TXT
$15.4B
| $22.7M | 0.05% |
385,093
-362,632
| -48% | -$21.3M |
|
297
Pitney Bowes
PBI
$2.39B
| $22.5M | 0.05% |
2,063,668
+1,201,017
| +139% | +$14.9M |
|
298
Bruker
BRKR
$8.14B
| $22.4M | 0.05% |
748,270
+271,746
| +57% | +$8.82M |
|
299
ManpowerGroup
MAN
$2.63B
| $22.4M | 0.05% |
194,247
-66,600
| -26% | -$8.23M |
|
|
HDS
300
DELISTED
HD Supply Holdings, Inc.
HDS
| $22.2M | 0.05% |
585,450
+360,972
| +161% | +$13.6M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.